JP2006003347A - Highly sensitive detection method for organic compound, and device used therefor - Google Patents
Highly sensitive detection method for organic compound, and device used therefor Download PDFInfo
- Publication number
- JP2006003347A JP2006003347A JP2005144454A JP2005144454A JP2006003347A JP 2006003347 A JP2006003347 A JP 2006003347A JP 2005144454 A JP2005144454 A JP 2005144454A JP 2005144454 A JP2005144454 A JP 2005144454A JP 2006003347 A JP2006003347 A JP 2006003347A
- Authority
- JP
- Japan
- Prior art keywords
- organic compound
- metal element
- compound
- conjugate
- containing compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000002894 organic compounds Chemical class 0.000 title claims abstract description 58
- 238000000034 method Methods 0.000 title claims abstract description 34
- 238000011896 sensitive detection Methods 0.000 title description 2
- 229910052751 metal Inorganic materials 0.000 claims abstract description 58
- 239000002184 metal Substances 0.000 claims abstract description 58
- 150000001875 compounds Chemical class 0.000 claims abstract description 55
- 238000004458 analytical method Methods 0.000 claims abstract description 47
- 239000003446 ligand Substances 0.000 claims description 28
- 238000004587 chromatography analysis Methods 0.000 claims description 11
- 229910052738 indium Inorganic materials 0.000 claims description 10
- APFVFJFRJDLVQX-UHFFFAOYSA-N indium atom Chemical compound [In] APFVFJFRJDLVQX-UHFFFAOYSA-N 0.000 claims description 10
- 238000001095 inductively coupled plasma mass spectrometry Methods 0.000 claims description 8
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 claims description 6
- 230000015572 biosynthetic process Effects 0.000 claims description 6
- 229910052707 ruthenium Inorganic materials 0.000 claims description 6
- 238000001479 atomic absorption spectroscopy Methods 0.000 claims description 5
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 5
- 229910052737 gold Inorganic materials 0.000 claims description 5
- 239000010931 gold Substances 0.000 claims description 5
- 229910052693 Europium Inorganic materials 0.000 claims description 4
- 229910052771 Terbium Inorganic materials 0.000 claims description 4
- 229910052775 Thulium Inorganic materials 0.000 claims description 4
- OGPBJKLSAFTDLK-UHFFFAOYSA-N europium atom Chemical compound [Eu] OGPBJKLSAFTDLK-UHFFFAOYSA-N 0.000 claims description 4
- 229910052703 rhodium Inorganic materials 0.000 claims description 4
- 239000010948 rhodium Substances 0.000 claims description 4
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 claims description 4
- GZCRRIHWUXGPOV-UHFFFAOYSA-N terbium atom Chemical compound [Tb] GZCRRIHWUXGPOV-UHFFFAOYSA-N 0.000 claims description 4
- 238000011097 chromatography purification Methods 0.000 claims description 3
- 230000007704 transition Effects 0.000 claims description 2
- 238000002354 inductively-coupled plasma atomic emission spectroscopy Methods 0.000 claims 1
- 238000007796 conventional method Methods 0.000 abstract description 2
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 39
- 239000003153 chemical reaction reagent Substances 0.000 description 34
- 238000001514 detection method Methods 0.000 description 28
- 229940024606 amino acid Drugs 0.000 description 22
- 235000001014 amino acid Nutrition 0.000 description 22
- 150000001413 amino acids Chemical class 0.000 description 21
- 239000000243 solution Substances 0.000 description 21
- 239000000523 sample Substances 0.000 description 17
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 15
- 230000035945 sensitivity Effects 0.000 description 13
- 239000000126 substance Substances 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 10
- 108090000765 processed proteins & peptides Proteins 0.000 description 10
- -1 ethochlorbinol Chemical compound 0.000 description 8
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 235000011054 acetic acid Nutrition 0.000 description 6
- 125000003118 aryl group Chemical group 0.000 description 6
- 238000004128 high performance liquid chromatography Methods 0.000 description 6
- 150000007524 organic acids Chemical class 0.000 description 6
- 235000005985 organic acids Nutrition 0.000 description 6
- ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical group N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 description 5
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 5
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 5
- 239000007853 buffer solution Substances 0.000 description 5
- 239000013522 chelant Substances 0.000 description 5
- JCLFHZLOKITRCE-UHFFFAOYSA-N 4-pentoxyphenol Chemical compound CCCCCOC1=CC=C(O)C=C1 JCLFHZLOKITRCE-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 230000005526 G1 to G0 transition Effects 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 4
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 4
- 239000000538 analytical sample Substances 0.000 description 4
- 238000005251 capillar electrophoresis Methods 0.000 description 4
- 239000002207 metabolite Substances 0.000 description 4
- 239000006199 nebulizer Substances 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- QKFJKGMPGYROCL-UHFFFAOYSA-N phenyl isothiocyanate Chemical compound S=C=NC1=CC=CC=C1 QKFJKGMPGYROCL-UHFFFAOYSA-N 0.000 description 4
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- CUKWUWBLQQDQAC-VEQWQPCFSA-N (3s)-3-amino-4-[[(2s)-1-[[(2s)-1-[[(2s)-1-[[(2s,3s)-1-[[(2s)-1-[(2s)-2-[[(1s)-1-carboxyethyl]carbamoyl]pyrrolidin-1-yl]-3-(1h-imidazol-5-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-methyl-1-ox Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C1=CC=C(O)C=C1 CUKWUWBLQQDQAC-VEQWQPCFSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- VHMWJVAFPCGUTJ-UHFFFAOYSA-N 2-[[2-[bis(carboxymethyl)amino]-3-(4-isothiocyanatophenyl)propyl]-(carboxymethyl)amino]acetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(N(CC(O)=O)CC(O)=O)CC1=CC=C(N=C=S)C=C1 VHMWJVAFPCGUTJ-UHFFFAOYSA-N 0.000 description 3
- 102000005862 Angiotensin II Human genes 0.000 description 3
- 101800000733 Angiotensin-2 Proteins 0.000 description 3
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 3
- 102000053602 DNA Human genes 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 3
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 102100029251 Phagocytosis-stimulating peptide Human genes 0.000 description 3
- 239000012327 Ruthenium complex Substances 0.000 description 3
- 108010084754 Tuftsin Proteins 0.000 description 3
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 3
- 239000008351 acetate buffer Substances 0.000 description 3
- 150000001299 aldehydes Chemical class 0.000 description 3
- 125000001931 aliphatic group Chemical group 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 229950006323 angiotensin ii Drugs 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- ACYBVNYNIZTUIL-UHFFFAOYSA-N n'-benzylethane-1,2-diamine Chemical compound NCCNCC1=CC=CC=C1 ACYBVNYNIZTUIL-UHFFFAOYSA-N 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 239000008055 phosphate buffer solution Substances 0.000 description 3
- 239000000376 reactant Substances 0.000 description 3
- 229920002477 rna polymer Polymers 0.000 description 3
- 229910052717 sulfur Inorganic materials 0.000 description 3
- RMVRSNDYEFQCLF-UHFFFAOYSA-N thiophenol Chemical compound SC1=CC=CC=C1 RMVRSNDYEFQCLF-UHFFFAOYSA-N 0.000 description 3
- IESDGNYHXIOKRW-LEOABGAYSA-N tuftsin Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@H](CCCNC(N)=N)C(O)=O IESDGNYHXIOKRW-LEOABGAYSA-N 0.000 description 3
- 229940035670 tuftsin Drugs 0.000 description 3
- HNSDLXPSAYFUHK-UHFFFAOYSA-N 1,4-bis(2-ethylhexyl) sulfosuccinate Chemical compound CCCCC(CC)COC(=O)CC(S(O)(=O)=O)C(=O)OCC(CC)CCCC HNSDLXPSAYFUHK-UHFFFAOYSA-N 0.000 description 2
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
- ZRKMQKLGEQPLNS-UHFFFAOYSA-N 1-Pentanethiol Chemical compound CCCCCS ZRKMQKLGEQPLNS-UHFFFAOYSA-N 0.000 description 2
- ZJJNYYDFJCYHTM-UHFFFAOYSA-N 2-(4-methylpyridin-2-yl)pyridine-4-carboxylic acid 2-pyridin-2-ylpyridine ruthenium Chemical compound [Ru].N1=CC=CC=C1C1=CC=CC=N1.N1=CC=CC=C1C1=CC=CC=N1.CC1=CC=NC(C=2N=CC=C(C=2)C(O)=O)=C1 ZJJNYYDFJCYHTM-UHFFFAOYSA-N 0.000 description 2
- HSJKGGMUJITCBW-UHFFFAOYSA-N 3-hydroxybutanal Chemical compound CC(O)CC=O HSJKGGMUJITCBW-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 2
- 239000005695 Ammonium acetate Substances 0.000 description 2
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 2
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 2
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 229940100514 Syk tyrosine kinase inhibitor Drugs 0.000 description 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 235000019257 ammonium acetate Nutrition 0.000 description 2
- 229940043376 ammonium acetate Drugs 0.000 description 2
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 2
- 125000003710 aryl alkyl group Chemical group 0.000 description 2
- 235000003704 aspartic acid Nutrition 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 2
- 239000004327 boric acid Substances 0.000 description 2
- 108010059485 brain synaptic membrane glycoprotein gp 50 Proteins 0.000 description 2
- WQAQPCDUOCURKW-UHFFFAOYSA-N butanethiol Chemical compound CCCCS WQAQPCDUOCURKW-UHFFFAOYSA-N 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- WOZVHXUHUFLZGK-UHFFFAOYSA-N dimethyl terephthalate Chemical compound COC(=O)C1=CC=C(C(=O)OC)C=C1 WOZVHXUHUFLZGK-UHFFFAOYSA-N 0.000 description 2
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000004993 emission spectroscopy Methods 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 150000002440 hydroxy compounds Chemical class 0.000 description 2
- 238000009616 inductively coupled plasma Methods 0.000 description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 238000000121 microwave-induced plasma mass spectrometry Methods 0.000 description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 description 2
- 239000002777 nucleoside Substances 0.000 description 2
- 229940054441 o-phthalaldehyde Drugs 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229940117953 phenylisothiocyanate Drugs 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- ZWLUXSQADUDCSB-UHFFFAOYSA-N phthalaldehyde Chemical compound O=CC1=CC=CC=C1C=O ZWLUXSQADUDCSB-UHFFFAOYSA-N 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 125000004434 sulfur atom Chemical group 0.000 description 2
- 150000003573 thiols Chemical class 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 229910021642 ultra pure water Inorganic materials 0.000 description 2
- 239000012498 ultrapure water Substances 0.000 description 2
- 239000004474 valine Substances 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- AUHDWARTFSKSAC-HEIFUQTGSA-N (2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-(6-oxo-1H-purin-9-yl)oxolane-2-carboxylic acid Chemical compound [C@]1([C@H](O)[C@H](O)[C@@H](CO)O1)(N1C=NC=2C(O)=NC=NC12)C(=O)O AUHDWARTFSKSAC-HEIFUQTGSA-N 0.000 description 1
- IESDGNYHXIOKRW-YXMSTPNBSA-N (2s)-2-[[(2s)-1-[(2s)-6-amino-2-[[(2s,3r)-2-amino-3-hydroxybutanoyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O IESDGNYHXIOKRW-YXMSTPNBSA-N 0.000 description 1
- KEOPTZKJOKJEIM-VDNREOAASA-N (4s)-4-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s,3s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-4-methylpentanoyl]amino]-3-methylpentanoyl]amino]-4-carboxybutanoyl]amino]-3-carboxyprop Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(O)=O)CC1=CC=C(O)C=C1 KEOPTZKJOKJEIM-VDNREOAASA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- UHDGCWIWMRVCDJ-UHFFFAOYSA-N 1-beta-D-Xylofuranosyl-NH-Cytosine Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1 UHDGCWIWMRVCDJ-UHFFFAOYSA-N 0.000 description 1
- KJCVRFUGPWSIIH-UHFFFAOYSA-N 1-naphthol Chemical compound C1=CC=C2C(O)=CC=CC2=C1 KJCVRFUGPWSIIH-UHFFFAOYSA-N 0.000 description 1
- KHWCHTKSEGGWEX-RRKCRQDMSA-N 2'-deoxyadenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(O)=O)O1 KHWCHTKSEGGWEX-RRKCRQDMSA-N 0.000 description 1
- NCMVOABPESMRCP-SHYZEUOFSA-N 2'-deoxycytosine 5'-monophosphate Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)C1 NCMVOABPESMRCP-SHYZEUOFSA-N 0.000 description 1
- YKBGVTZYEHREMT-KVQBGUIXSA-N 2'-deoxyguanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](CO)O1 YKBGVTZYEHREMT-KVQBGUIXSA-N 0.000 description 1
- LTFMZDNNPPEQNG-KVQBGUIXSA-N 2'-deoxyguanosine 5'-monophosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@H]1C[C@H](O)[C@@H](COP(O)(O)=O)O1 LTFMZDNNPPEQNG-KVQBGUIXSA-N 0.000 description 1
- VILCJCGEZXAXTO-UHFFFAOYSA-N 2,2,2-tetramine Chemical compound NCCNCCNCCN VILCJCGEZXAXTO-UHFFFAOYSA-N 0.000 description 1
- ONNFHVZYYHMFOS-UHFFFAOYSA-N 2,2-dichloro-n-ethylethanamine Chemical compound CCNCC(Cl)Cl ONNFHVZYYHMFOS-UHFFFAOYSA-N 0.000 description 1
- RHVCCFKUACIGSM-UHFFFAOYSA-N 2,3,4,6,7,11b-hexahydro-1h-benzo[a]quinolizine Chemical class C1CC2=CC=CC=C2C2N1CCCC2 RHVCCFKUACIGSM-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- NYOGGQBMEGUVIX-WCCKRBBISA-N 2-aminoacetic acid;(2s)-2-amino-3-methylbutanoic acid Chemical compound NCC(O)=O.CC(C)[C@H](N)C(O)=O NYOGGQBMEGUVIX-WCCKRBBISA-N 0.000 description 1
- DQSIXGDDUJJEQH-QRPNPIFTSA-N 2-aminoacetic acid;(2s)-2-amino-3-phenylpropanoic acid Chemical compound NCC(O)=O.OC(=O)[C@@H](N)CC1=CC=CC=C1 DQSIXGDDUJJEQH-QRPNPIFTSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- CKTSBUTUHBMZGZ-ULQXZJNLSA-N 4-amino-1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-tritiopyrimidin-2-one Chemical compound O=C1N=C(N)C([3H])=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 CKTSBUTUHBMZGZ-ULQXZJNLSA-N 0.000 description 1
- MBVFRSJFKMJRHA-UHFFFAOYSA-N 4-fluoro-1-benzofuran-7-carbaldehyde Chemical compound FC1=CC=C(C=O)C2=C1C=CO2 MBVFRSJFKMJRHA-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- HGINCPLSRVDWNT-UHFFFAOYSA-N Acrolein Chemical compound C=CC=O HGINCPLSRVDWNT-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical group NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- UDMBCSSLTHHNCD-UHFFFAOYSA-N Coenzym Q(11) Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-UHFFFAOYSA-N 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- UHDGCWIWMRVCDJ-PSQAKQOGSA-N Cytidine Natural products O=C1N=C(N)C=CN1[C@@H]1[C@@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-PSQAKQOGSA-N 0.000 description 1
- 229930183912 Cytidylic acid Natural products 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 1
- XPDXVDYUQZHFPV-UHFFFAOYSA-N Dansyl Chloride Chemical compound C1=CC=C2C(N(C)C)=CC=CC2=C1S(Cl)(=O)=O XPDXVDYUQZHFPV-UHFFFAOYSA-N 0.000 description 1
- RPNUMPOLZDHAAY-UHFFFAOYSA-N Diethylenetriamine Chemical compound NCCNCCN RPNUMPOLZDHAAY-UHFFFAOYSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical class S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 229910052688 Gadolinium Inorganic materials 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- 229930010555 Inosine Natural products 0.000 description 1
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
- GRSZFWQUAKGDAV-UHFFFAOYSA-N Inosinic acid Natural products OC1C(O)C(COP(O)(O)=O)OC1N1C(NC=NC2=O)=C2N=C1 GRSZFWQUAKGDAV-UHFFFAOYSA-N 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 125000000393 L-methionino group Chemical group [H]OC(=O)[C@@]([H])(N([H])[*])C([H])([H])C(SC([H])([H])[H])([H])[H] 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- GHGSXSFHVYYNAP-UHFFFAOYSA-N N(C(=O)N)[S] Chemical compound N(C(=O)N)[S] GHGSXSFHVYYNAP-UHFFFAOYSA-N 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 1
- NHFPQEWGDJGKPO-OMSMUOAWSA-N NCC(O)=O.CC(C)[C@H](N)C(O)=O.OC(=O)[C@@H](N)CC1=CC=CC=C1 Chemical compound NCC(O)=O.CC(C)[C@H](N)C(O)=O.OC(=O)[C@@H](N)CC1=CC=CC=C1 NHFPQEWGDJGKPO-OMSMUOAWSA-N 0.000 description 1
- DAYLJWODMCOQEW-TURQNECASA-O NMN(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(O)=O)O2)O)=C1 DAYLJWODMCOQEW-TURQNECASA-O 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- CJHQRDOJZKLYPN-JZGIKJSDSA-M P(=O)(O)(O)[O-].[Na+].N[C@@H](CC1=CC=CC=C1)C(=O)O Chemical compound P(=O)(O)(O)[O-].[Na+].N[C@@H](CC1=CC=CC=C1)C(=O)O CJHQRDOJZKLYPN-JZGIKJSDSA-M 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
- 108091028664 Ribonucleotide Proteins 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- DJJCXFVJDGTHFX-UHFFFAOYSA-N Uridinemonophosphate Natural products OC1C(O)C(COP(O)(O)=O)OC1N1C(=O)NC(=O)C=C1 DJJCXFVJDGTHFX-UHFFFAOYSA-N 0.000 description 1
- FOGRQMPFHUHIGU-UHFFFAOYSA-N Uridylic acid Natural products OC1C(OP(O)(O)=O)C(CO)OC1N1C(=O)NC(=O)C=C1 FOGRQMPFHUHIGU-UHFFFAOYSA-N 0.000 description 1
- 229910052769 Ytterbium Inorganic materials 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 1
- 150000001243 acetic acids Chemical class 0.000 description 1
- 229940114077 acrylic acid Drugs 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 1
- 229950006790 adenosine phosphate Drugs 0.000 description 1
- 238000005377 adsorption chromatography Methods 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- WUOACPNHFRMFPN-UHFFFAOYSA-N alpha-terpineol Chemical compound CC1=CCC(C(C)(C)O)CC1 WUOACPNHFRMFPN-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 150000001409 amidines Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 229910000074 antimony hydride Inorganic materials 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 108010060350 arginyl-arginyl-leucyl-isoleucyl-glutamyl-aspartyl-alanyl-glutamyl-tyrosyl-alanyl-alanyl-arginyl-glycine Proteins 0.000 description 1
- RBFQJDQYXXHULB-UHFFFAOYSA-N arsane Chemical compound [AsH3] RBFQJDQYXXHULB-UHFFFAOYSA-N 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
- DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- VTJUKNSKBAOEHE-UHFFFAOYSA-N calixarene Chemical compound COC(=O)COC1=C(CC=2C(=C(CC=3C(=C(C4)C=C(C=3)C(C)(C)C)OCC(=O)OC)C=C(C=2)C(C)(C)C)OCC(=O)OC)C=C(C(C)(C)C)C=C1CC1=C(OCC(=O)OC)C4=CC(C(C)(C)C)=C1 VTJUKNSKBAOEHE-UHFFFAOYSA-N 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 150000003857 carboxamides Chemical class 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 150000001733 carboxylic acid esters Chemical class 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- FOCAUTSVDIKZOP-UHFFFAOYSA-N chloroacetic acid Chemical compound OC(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-N 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- UHDGCWIWMRVCDJ-ZAKLUEHWSA-N cytidine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-ZAKLUEHWSA-N 0.000 description 1
- IERHLVCPSMICTF-XVFCMESISA-N cytidine 5'-monophosphate Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(O)=O)O1 IERHLVCPSMICTF-XVFCMESISA-N 0.000 description 1
- IERHLVCPSMICTF-UHFFFAOYSA-N cytidine monophosphate Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(COP(O)(O)=O)O1 IERHLVCPSMICTF-UHFFFAOYSA-N 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- KHWCHTKSEGGWEX-UHFFFAOYSA-N deoxyadenylic acid Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(O)=O)O1 KHWCHTKSEGGWEX-UHFFFAOYSA-N 0.000 description 1
- LTFMZDNNPPEQNG-UHFFFAOYSA-N deoxyguanylic acid Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1CC(O)C(COP(O)(O)=O)O1 LTFMZDNNPPEQNG-UHFFFAOYSA-N 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- FPIQZBQZKBKLEI-UHFFFAOYSA-N ethyl 1-[[2-chloroethyl(nitroso)carbamoyl]amino]cyclohexane-1-carboxylate Chemical compound ClCCN(N=O)C(=O)NC1(C(=O)OCC)CCCCC1 FPIQZBQZKBKLEI-UHFFFAOYSA-N 0.000 description 1
- 235000019439 ethyl acetate Nutrition 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 235000019162 flavin adenine dinucleotide Nutrition 0.000 description 1
- 239000011714 flavin adenine dinucleotide Substances 0.000 description 1
- VWWQXMAJTJZDQX-UYBVJOGSSA-N flavin adenine dinucleotide Chemical compound C1=NC2=C(N)N=CN=C2N1[C@@H]([C@H](O)[C@@H]1O)O[C@@H]1CO[P@](O)(=O)O[P@@](O)(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C2=NC(=O)NC(=O)C2=NC2=C1C=C(C)C(C)=C2 VWWQXMAJTJZDQX-UYBVJOGSSA-N 0.000 description 1
- FVTCRASFADXXNN-SCRDCRAPSA-N flavin mononucleotide Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-SCRDCRAPSA-N 0.000 description 1
- FVTCRASFADXXNN-UHFFFAOYSA-N flavin mononucleotide Natural products OP(=O)(O)OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-UHFFFAOYSA-N 0.000 description 1
- 239000011768 flavin mononucleotide Substances 0.000 description 1
- 229940013640 flavin mononucleotide Drugs 0.000 description 1
- 229940093632 flavin-adenine dinucleotide Drugs 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- UIWYJDYFSGRHKR-UHFFFAOYSA-N gadolinium atom Chemical compound [Gd] UIWYJDYFSGRHKR-UHFFFAOYSA-N 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 238000005227 gel permeation chromatography Methods 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 238000001036 glow-discharge mass spectrometry Methods 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- ZRALSGWEFCBTJO-UHFFFAOYSA-O guanidinium Chemical compound NC(N)=[NH2+] ZRALSGWEFCBTJO-UHFFFAOYSA-O 0.000 description 1
- 229940029575 guanosine Drugs 0.000 description 1
- RQFCJASXJCIDSX-UUOKFMHZSA-N guanosine 5'-monophosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O RQFCJASXJCIDSX-UUOKFMHZSA-N 0.000 description 1
- 235000013928 guanylic acid Nutrition 0.000 description 1
- 239000004226 guanylic acid Substances 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000001927 high performance liquid chromatography-inductively coupled plasma mass spectrometry Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- ORTFAQDWJHRMNX-UHFFFAOYSA-N hydroxidooxidocarbon(.) Chemical group O[C]=O ORTFAQDWJHRMNX-UHFFFAOYSA-N 0.000 description 1
- XLSMFKSTNGKWQX-UHFFFAOYSA-N hydroxyacetone Chemical compound CC(=O)CO XLSMFKSTNGKWQX-UHFFFAOYSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- SRNMFPSMASDEKJ-UHFFFAOYSA-N indium;nitric acid Chemical compound [In].O[N+]([O-])=O SRNMFPSMASDEKJ-UHFFFAOYSA-N 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229960003786 inosine Drugs 0.000 description 1
- 235000013902 inosinic acid Nutrition 0.000 description 1
- 239000004245 inosinic acid Substances 0.000 description 1
- 229940028843 inosinic acid Drugs 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- WOLFCKKMHUVEPN-UHFFFAOYSA-N n-ethyl-n-methylbutan-1-amine Chemical compound CCCCN(C)CC WOLFCKKMHUVEPN-UHFFFAOYSA-N 0.000 description 1
- ALIFPGGMJDWMJH-UHFFFAOYSA-N n-phenyldiazenylaniline Chemical compound C=1C=CC=CC=1NN=NC1=CC=CC=C1 ALIFPGGMJDWMJH-UHFFFAOYSA-N 0.000 description 1
- 229950006238 nadide Drugs 0.000 description 1
- XBCIOBSQHJYVBQ-UHFFFAOYSA-N naphthalen-1-ylhydrazine Chemical compound C1=CC=C2C(NN)=CC=CC2=C1 XBCIOBSQHJYVBQ-UHFFFAOYSA-N 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 150000003833 nucleoside derivatives Chemical class 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229960002969 oleic acid Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229910052762 osmium Inorganic materials 0.000 description 1
- SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium atom Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 description 1
- 150000002923 oximes Chemical class 0.000 description 1
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 description 1
- 238000004816 paper chromatography Methods 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 238000004810 partition chromatography Methods 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- QCCDLTOVEPVEJK-UHFFFAOYSA-N phenylacetone Chemical compound CC(=O)CC1=CC=CC=C1 QCCDLTOVEPVEJK-UHFFFAOYSA-N 0.000 description 1
- MTZWHHIREPJPTG-UHFFFAOYSA-N phorone Chemical compound CC(C)=CC(=O)C=C(C)C MTZWHHIREPJPTG-UHFFFAOYSA-N 0.000 description 1
- 229930193351 phorone Natural products 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 150000004032 porphyrins Chemical class 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019231 riboflavin-5'-phosphate Nutrition 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229960004274 stearic acid Drugs 0.000 description 1
- OUULRIDHGPHMNQ-UHFFFAOYSA-N stibane Chemical compound [SbH3] OUULRIDHGPHMNQ-UHFFFAOYSA-N 0.000 description 1
- 125000000547 substituted alkyl group Chemical group 0.000 description 1
- 125000003107 substituted aryl group Chemical group 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- 125000002480 thymidyl group Chemical group 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 239000011135 tin Substances 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- 150000003624 transition metals Chemical class 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 1
- 229940045145 uridine Drugs 0.000 description 1
- DJJCXFVJDGTHFX-XVFCMESISA-N uridine 5'-monophosphate Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(=O)NC(=O)C=C1 DJJCXFVJDGTHFX-XVFCMESISA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 238000004876 x-ray fluorescence Methods 0.000 description 1
- 125000002256 xylenyl group Chemical class C1(C(C=CC=C1)C)(C)* 0.000 description 1
- NAWDYIZEMPQZHO-UHFFFAOYSA-N ytterbium Chemical compound [Yb] NAWDYIZEMPQZHO-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Abstract
Description
本発明は、有機化合物の新規高感度検出方法およびそれに用いる装置に関する。より詳細には、検出対象の有機化合物に対する結合能を有する金属含有標識試薬により検出対象の有機化合物を標識し、その標識化有機化合物を無機分析で分析することを含む、有機化合物の高感度検出方法およびそれに用いる装置に関する。 The present invention relates to a novel highly sensitive detection method for organic compounds and an apparatus used therefor. More specifically, high-sensitivity detection of an organic compound, including labeling the organic compound to be detected with a metal-containing labeling reagent capable of binding to the organic compound to be detected, and analyzing the labeled organic compound by inorganic analysis The present invention relates to a method and an apparatus used therefor.
アミノ酸や有機酸などの有機化合物を分析する手法としては、o−フタルアルデヒド(OPA)、ダンシルクロライド、フェニルイソチオシアネート(PITC)といった誘導体化試薬を対象化合物と反応させ、誘導体化試薬の紫外吸収や蛍光を測定することで、間接的に対象化合物の検出や定量を行う方法が一般的である。しかし、これらの手法は対象化合物の種類によって検出感度が大きく異なってしまうため、精製した標準試料がなければ試料中の対象化合物の濃度を比較することも定量することもできない。ところが、アミノ酸や有機酸に代表される代謝物には不安定な物質が多く、種類も非常に多いので、標準試料は大変入手し難い。このような理由により、有機化合物の濃度の比較は極めて困難であった。 As a method for analyzing organic compounds such as amino acids and organic acids, a derivatizing reagent such as o-phthalaldehyde (OPA), dansyl chloride, phenyl isothiocyanate (PITC) is reacted with the target compound, A method of indirectly detecting or quantifying a target compound by measuring fluorescence is common. However, since the detection sensitivities of these techniques vary greatly depending on the type of the target compound, the concentration of the target compound in the sample cannot be compared or quantified without a purified standard sample. However, metabolites represented by amino acids and organic acids have many unstable substances and very many kinds, so it is difficult to obtain standard samples. For these reasons, it has been extremely difficult to compare the concentrations of organic compounds.
また、前述したような誘導体化試薬以外で有機化合物を分析する方法としては、他に金属キレート試薬を用いた発光プローブ分析がある。発光プローブ分析は金属を中心に担持するキレート化合物の化学発光を検出することによって、試料中のアミノ酸や有機酸などの化合物を分析することができる。しかし、この手法は検出限界がpmolオーダーであり、細胞内のアミノ酸や有機酸などの代謝物を検出するためには、数十万個の細胞を必要とする。このため、多量のサンプルを採取しなくてはならないため生体に対しての負担が大きく、分析できるものは血液や組織など、サンプルが大量に手に入るものに限られてしまう。その結果、サンプル量の少ないものは分析できず、臨床検査や生体の経時分析に利用することはできなかった。 Further, as a method for analyzing an organic compound other than the derivatizing reagent as described above, there is a luminescent probe analysis using a metal chelate reagent. Luminescent probe analysis can analyze compounds such as amino acids and organic acids in a sample by detecting chemiluminescence of a chelate compound supported mainly on a metal. However, this technique has a detection limit on the order of pmol, and requires several hundreds of thousands of cells to detect intracellular metabolites such as amino acids and organic acids. For this reason, since it is necessary to collect a large amount of samples, the burden on the living body is large, and what can be analyzed is limited to those that can be obtained in large quantities such as blood and tissues. As a result, samples with a small amount of sample could not be analyzed, and could not be used for clinical examinations or biological analysis over time.
誘導体化試薬を使った有機化合物の検出に関する文献としては、非特許文献1〜4などが挙げられ、これらの文献はいずれも紫外吸収や蛍光など光を検出手段として用いている。 Non-patent documents 1 to 4 and the like are cited as documents relating to the detection of organic compounds using a derivatizing reagent, and these documents all use light such as ultraviolet absorption and fluorescence as detection means.
特許文献1は、ルテニウム錯体化学発光によるクロマト検出用試薬を記載している。この試薬によれば、カルボン酸、1級アミンおよびアルコールを検出することができるが、検出感度はpmolレベルであり、十分な検出感度が得られているとは言えない。 Patent Document 1 describes a reagent for chromatographic detection by ruthenium complex chemiluminescence. According to this reagent, carboxylic acid, primary amine and alcohol can be detected, but the detection sensitivity is at the pmol level, and it cannot be said that sufficient detection sensitivity is obtained.
特許文献2は、ベンゾキノリジジン誘導体を含有するカルボン酸のルテニウム錯体化学発光検出用試薬を記載している。この試薬によれば、試料中のカルボン酸を検出することができるが、特許文献1と同様、検出感度はpmolレベルであり、十分な検出感度が得られているとは言えない。 Patent Document 2 describes a reagent for detecting a ruthenium complex chemiluminescence of a carboxylic acid containing a benzoquinolizidine derivative. According to this reagent, carboxylic acid in a sample can be detected. However, like Patent Document 1, the detection sensitivity is at the pmol level, and it cannot be said that sufficient detection sensitivity is obtained.
非特許文献5は、DNA/RNAアッセイのプローブとして白金錯体を使用している。この文献では、化合物をオリゴヌクレオチドと反応させた場合に生じる発光線を検出している。しかし、この文献に記載の方法は検出感度も低く、また、分離検出を目的とする方法ではないため化合物ごとの検出は不可能である。
上述したように従来の有機化合物の検出方法は十分な検出感度が得られているとは言えず、より高感度な有機化合物の検出方法の創出が望まれていた。本発明はこのような状況を鑑み、微量の有機化合物を従来法に比較して高感度かつ迅速に分析する方法を提供することを課題とした。 As described above, the conventional organic compound detection method cannot be said to have sufficient detection sensitivity, and the creation of a more sensitive organic compound detection method has been desired. In view of such circumstances, an object of the present invention is to provide a method for analyzing a trace amount of an organic compound with high sensitivity and speed as compared with a conventional method.
本発明の要旨は以下のとおりである。
〔1〕 (1)有機化合物と金属元素含有化合物との結合体を生成する工程と、
(2)該結合体を無機分析に供して該結合体に含有される金属元素を分析する工程と
を含む、有機化合物の分析方法。
〔2〕 前記金属元素含有化合物が、式:
[Mv(R)m(L1)n(L2)o(L3)p(L4)q(L5)r(L6)s]tSu
〔式中、
Mは、無機分析で検出可能な金属元素であり、
Rは、Mの多座配位リガンドであり、
L1、L2、L3、L4、L5およびL6はMのリガンドであって、それぞれが同一でも異なっていてもよく、
Sは前記有機化合物と結合可能な反応性部位を有する基であって、R、L1、L2、L3、L4、L5およびL6のうちの1個以上と共有結合しており、
m、t、uおよびvはそれぞれ独立して1以上の整数であり、
n、o、p、q、rおよびsはそれぞれ独立して0または1以上の整数である〕
で表される、上記〔1〕に記載の方法。
〔3〕 Mが、遷移元素である、上記〔2〕に記載の方法。
〔4〕 Mが、ルテニウム、インジウム、テルビウム、ツリウム、ユーロピウム、ロジウムおよび金からなる群から選ばれる、上記〔2〕に記載の方法。
〔5〕 有機化合物と金属元素含有化合物との結合体の生成が、有機化合物に金属元素含有化合物を結合させることによるものである、上記〔1〕に記載の方法。
〔6〕 有機化合物と金属元素含有化合物との結合体の生成が、有機化合物に多座配位子リガンドまたはリガンドを結合させた後に金属元素を結合させることによるものである、上記〔1〕に記載の方法。
〔7〕 前記無機分析が、ICP−MS、ICP−AESまたはAASである、上記〔1〕〜〔6〕のいずれかに記載の方法。
〔8〕 クロマトグラフィー精製工程をさらに含む、上記〔1〕〜〔7〕のいずれかに記載の方法。
〔9〕 有機化合物と金属元素含有化合物との結合体中の金属元素を分析する無機分析手段を備える、有機化合物の分析装置。
〔10〕 有機化合物と金属元素含有化合物との結合体を精製するクロマトグラフィー手段をさらに備える、上記〔9〕に記載の装置。
The gist of the present invention is as follows.
[1] (1) A step of producing a conjugate of an organic compound and a metal element-containing compound;
(2) A method for analyzing an organic compound, comprising: subjecting the conjugate to an inorganic analysis and analyzing a metal element contained in the conjugate.
[2] The metal element-containing compound has the formula:
[M v (R) m (L1) n (L2) o (L3) p (L4) q (L5) r (L6) s ] t Su
[Where,
M is a metal element detectable by inorganic analysis,
R is a multidentate ligand of M;
L1, L2, L3, L4, L5 and L6 are ligands of M, which may be the same or different,
S is a group having a reactive site capable of binding to the organic compound, and is covalently bonded to one or more of R, L1, L2, L3, L4, L5 and L6;
m, t, u and v are each independently an integer of 1 or more,
n, o, p, q, r and s are each independently 0 or an integer of 1 or more.]
The method according to [1] above, represented by:
[3] The method according to [2] above, wherein M is a transition element.
[4] The method according to [2] above, wherein M is selected from the group consisting of ruthenium, indium, terbium, thulium, europium, rhodium and gold.
[5] The method according to [1] above, wherein the formation of the conjugate of the organic compound and the metal element-containing compound is caused by bonding the metal element-containing compound to the organic compound.
[6] In the above [1], the formation of a conjugate of an organic compound and a metal element-containing compound is caused by binding a metal element after binding a multidentate ligand ligand or a ligand to the organic compound. The method described.
[7] The method according to any one of [1] to [6], wherein the inorganic analysis is ICP-MS, ICP-AES, or AAS.
[8] The method according to any one of [1] to [7], further including a chromatography purification step.
[9] An organic compound analyzer comprising an inorganic analysis means for analyzing a metal element in a combined body of an organic compound and a metal element-containing compound.
[10] The apparatus according to [9], further comprising a chromatography means for purifying a conjugate of the organic compound and the metal element-containing compound.
本発明により、従来は分析が困難であった極微量の有機化合物の検出が可能となり、生体内の代謝物分析などの生命科学や医療の分野および環境科学の分野における分析などにおいて、有効な分析手段を提供することが可能となる。また、本発明は、金属元素含有化合物を標識として用いて有機化合物を間接的に分析するので、分析感度が有機化合物の種類に影響されない。さらには、本発明は分析対象の標準品がなくても定量が可能であるため、未知試料の分析を行うことも可能である。 The present invention makes it possible to detect trace amounts of organic compounds that were difficult to analyze in the past, and is effective in analysis in the fields of life sciences, medical treatments, and environmental sciences such as in vivo metabolite analysis. Means can be provided. Moreover, since this invention analyzes an organic compound indirectly using a metal element containing compound as a label | marker, an analysis sensitivity is not influenced by the kind of organic compound. Furthermore, since the present invention can be quantified without a standard product to be analyzed, an unknown sample can be analyzed.
本発明の有機化合物の分析方法は、以下の2つの工程を含む。
(1)対象となる有機化合物と金属元素含有化合物との結合体を生成する工程
(2)該結合体を無機分析に供して該結合体に含有される金属元素を分析する工程
The organic compound analysis method of the present invention includes the following two steps.
(1) A step of generating a conjugate of a target organic compound and a metal element-containing compound (2) A step of subjecting the conjugate to an inorganic analysis and analyzing a metal element contained in the conjugate
本発明は、金属元素含有化合物と有機化合物との結合部となるリガンド部分を適宜選択すればよいため、如何なる有機化合物でも分析可能である。有機化合物と金属含有化合物との結合はいかなる結合であってもよいが、例として、共有結合、イオン結合、配位結合などが挙げられる。 In the present invention, any organic compound can be analyzed because a ligand portion that serves as a binding portion between the metal element-containing compound and the organic compound may be appropriately selected. The bond between the organic compound and the metal-containing compound may be any bond, and examples thereof include a covalent bond, an ionic bond, and a coordinate bond.
本発明における有機化合物と金属元素含有化合物との結合体の生成には、有機化合物に金属元素含有化合物を結合させて結合体を生成する場合のほか、有機化合物に多座配位子リガンド(R)またはリガンド(L1、L2、L3、L4、L5およびL6)を結合させた後に金属元素(M)を結合させて、最終的な形態として有機化合物と金属元素含有化合物とが結合した状態の結合体を生成する場合も含まれる。 In the present invention, a conjugate of an organic compound and a metal element-containing compound can be produced by combining a metal element-containing compound with an organic compound to produce a conjugate, or a multidentate ligand ligand (R ) Or ligands (L1, L2, L3, L4, L5, and L6), and then the metal element (M) is bonded to form a final form in which the organic compound and the metal element-containing compound are bonded. It also includes the case of generating a body.
本発明により特に好適に分析可能な有機化合物としては、アミノ酸、アミン、核酸塩基、ヌクレオシド、ヌクレオチド、有機酸、アルデヒド、ケトン、チオール、ヒドロキシ化合物、ペプチド、ポリペプチド、核酸、およびタンパク質などの高分子化合物が挙げられる。 Organic compounds that can be analyzed particularly preferably according to the present invention include macromolecules such as amino acids, amines, nucleobases, nucleosides, nucleotides, organic acids, aldehydes, ketones, thiols, hydroxy compounds, peptides, polypeptides, nucleic acids, and proteins. Compounds.
アミノ酸としては、例えば、グリシン、アラニン、バリン、ロイシン、イソロイシン、セリン、スレオニン、システイン、シスチン、メチオニン、フェニルアラニン、チロシン、トリプトファン、アスパラギン酸、グルタミン酸、アスパラギン、グルタミン、リシン、アルギニン、ヒスチジン、プロリン、オキシプロリンなどが挙げられる。 Examples of amino acids include glycine, alanine, valine, leucine, isoleucine, serine, threonine, cysteine, cystine, methionine, phenylalanine, tyrosine, tryptophan, aspartic acid, glutamic acid, asparagine, glutamine, lysine, arginine, histidine, proline, oxy Examples include proline.
アミンとしては、例えば、エタンアミン、ベンジルアミン、エチレンジアミン、ジエチルアミン、トリメチルアミン、ジクロロジエチルアミン、N−エチル−N−メチルブタン−1−アミン、ヒドロキシルアミン、ナフチルヒドラジン、ジアゾアミノベンゼンなどが挙げられる。 Examples of the amine include ethaneamine, benzylamine, ethylenediamine, diethylamine, trimethylamine, dichlorodiethylamine, N-ethyl-N-methylbutan-1-amine, hydroxylamine, naphthylhydrazine, diazoaminobenzene, and the like.
核酸塩基としては、例えば、アデニン、グアニン、シトシン、ウラシル、チミンなどが挙げられる。 Examples of the nucleobase include adenine, guanine, cytosine, uracil, thymine and the like.
ヌクレオシドとしては、例えば、アデノシン、グアノシン、シチジン、ウリジン、デオキシアデノシン、デオキシグアノシン、デオキシシチジン、チミジン、イノシン、ニコチンアミド、リボタイド、リボフラビンなどが挙げられる。 Examples of the nucleoside include adenosine, guanosine, cytidine, uridine, deoxyadenosine, deoxyguanosine, deoxycytidine, thymidine, inosine, nicotinamide, ribotide, riboflavin and the like.
ヌクレオチドとしては、例えば、アデニル酸、グアニル酸、シチジル酸、ウリジル酸、デオキシアデニル酸、デオキシグアニル酸、デオキシシチジル酸、チミジル酸、イノシン酸、ニコチンアミドモノヌクレオチド、ニコチンアミドアデニンジヌクレオチド、フラビンモノヌクレオチド、フラビンアデニンジヌクレオチドなどが挙げられる。 Examples of nucleotides include adenylic acid, guanylic acid, cytidylic acid, uridylic acid, deoxyadenylic acid, deoxyguanylic acid, deoxycytidylic acid, thymidyl acid, inosinic acid, nicotinamide mononucleotide, nicotinamide adenine dinucleotide, flavin mononucleotide Examples thereof include nucleotides and flavin adenine dinucleotide.
有機酸としては、例えば、ギ酸、酢酸、酢酸エチル、モノクロロ酢酸、ステアリン酸、アクリル酸、オレイン酸、リノレン酸、ピルビン酸、シクロヘキサンカルボン酸、安息香酸、無水マレイン酸、テレフタル酸ジメチル、乳酸、フタル酸などが挙げられる。 Examples of organic acids include formic acid, acetic acid, ethyl acetate, monochloroacetic acid, stearic acid, acrylic acid, oleic acid, linolenic acid, pyruvic acid, cyclohexanecarboxylic acid, benzoic acid, maleic anhydride, dimethyl terephthalate, lactic acid, phthalate An acid etc. are mentioned.
アルデヒドとしては、例えば、ホルムアルデヒド、アセトアルデヒド、ベンズアルデヒド、アルデヒドエーテル、バニリン、パラホルムアルデヒド、アクリルアルデヒド、シトラール、アルドールなどが挙げられる。 Examples of the aldehyde include formaldehyde, acetaldehyde, benzaldehyde, aldehyde ether, vanillin, paraformaldehyde, acrylic aldehyde, citral, aldol, and the like.
ケトンとしては、例えば、アセトン、メチルエチルケトン、樟脳、シクロヘキサン、フェニルアセトン、アントラキノン、ホロン、アセトールなどが挙げられる。 Examples of the ketone include acetone, methyl ethyl ketone, camphor, cyclohexane, phenylacetone, anthraquinone, phorone, and acetol.
チオールとしては、例えば、メチルメルカプタン、ブチルメルカプタン、ペンチルメルカプタン、チオフェノールなどが挙げられる。 Examples of the thiol include methyl mercaptan, butyl mercaptan, pentyl mercaptan, and thiophenol.
ヒドロキシ化合物としては、例えば、メタノール、プロパノール、ペンタノール、オクタノール、テルペンアルコール、エチレングリコール、ペンタエリトリトール、D−グルシトール、グリセリン、エトクロルビノール、フェノール、キシレノール、ナフトール、ヒドロキノンなどが挙げられる。 Examples of the hydroxy compound include methanol, propanol, pentanol, octanol, terpene alcohol, ethylene glycol, pentaerythritol, D-glucitol, glycerin, ethochlorbinol, phenol, xylenol, naphthol, hydroquinone, and the like.
ペプチドとしては、例えば、グリシン−バリン、フェニルアラニン−グリシン、アラニン−フェニルアラニン、チロシン−ロイシン、グリシン−バリン−フェニルアラニンなどが挙げられる。 Examples of the peptide include glycine-valine, phenylalanine-glycine, alanine-phenylalanine, tyrosine-leucine, glycine-valine-phenylalanine and the like.
ポリペプチドとしては、例えば、Arg−Arg−Leu−Ile−Glu−Asp−Ala−Glu−Tyr−Ala−Ala−Arg−Gly(配列番号1)などが挙げられる。 Examples of the polypeptide include Arg-Arg-Leu-Ile-Glu-Asp-Ala-Glu-Tyr-Ala-Ala-Arg-Gly (SEQ ID NO: 1).
核酸としては、例えば、デオキシリボ核酸(DNA)、リボ核酸(RNA)などが挙げられる。 Examples of the nucleic acid include deoxyribonucleic acid (DNA) and ribonucleic acid (RNA).
タンパク質としては、例えば、アルブミン、グロブリン、ケラチン、コラーゲン、フィブリノーゲンなどが挙げられる。 Examples of the protein include albumin, globulin, keratin, collagen, fibrinogen and the like.
本発明における金属元素含有化合物とは、無機分析で特異的に検出することが可能な、炭素、窒素、酸素、水素以外の金属原子を主とする無機原子を試薬構造に持ち、有機化合物と定量的に結合する能力を備えた物質である。 The metal element-containing compound in the present invention has an inorganic atom mainly composed of metal atoms other than carbon, nitrogen, oxygen and hydrogen, which can be specifically detected by inorganic analysis, in a reagent structure, and is quantified as an organic compound. A substance with the ability to bind physically.
本発明における金属元素含有化合物としては、式:
[Mv(R)m(L1)n(L2)o(L3)p(L4)q(L5)r(L6)s]tSu
で表される化合物が好ましい。
As the metal element-containing compound in the present invention, the formula:
[M v (R) m (L1) n (L2) o (L3) p (L4) q (L5) r (L6) s ] t Su
The compound represented by these is preferable.
上記式における各記号の定義は以下のとおりである。
Mは、無機分析で検出可能な金属元素である。そのような金属としては、ルテニウム、金、ユーロピウム、テルビウム、ツリウム、銅、イッテルビウム、インジウム、セレン、スズ、ロジウム、アルミニウム、ヒ素、オスミウム、ガドリニウムなどが例示されるが、なかでも、ルテニウム、インジウム、テルビウム、ツリウム、ユーロピウム、ロジウムおよび金が特に本発明に好適である。
また、Mとしては、周期表の第四周期以降の第3族〜第11族の遷移金属も、2価や3価になりうる金属であり、キレート化合物を作りやすい性質を持つため、好適である。
The definition of each symbol in the above formula is as follows.
M is a metal element that can be detected by inorganic analysis. Examples of such metals include ruthenium, gold, europium, terbium, thulium, copper, ytterbium, indium, selenium, tin, rhodium, aluminum, arsenic, osmium, gadolinium, etc., among others, ruthenium, indium, Terbium, thulium, europium, rhodium and gold are particularly suitable for the present invention.
Moreover, as M, the transition metal of the 3rd group-the 11th group after the 4th period of a periodic table is also a metal which can become bivalent or trivalent, and since it has the property which is easy to make a chelate compound, it is suitable. is there.
Rは、1種類以上のMの多座配位リガンドである。金属元素含有化合物が2つ以上の多座配位リガンドを有する場合には、複数の多座配位リガンドは互いに同じでも異なっていてもよい。多座配位リガンドは芳香族および脂肪族リガンドを含む。適当な芳香族多座配位リガンドは、窒素、酸素、リン、イオウなどを含む芳香族多座配位リガンドである。好ましい芳香族多座配位リガンドは、例えば、ビピリジル、ビピラジル、テルピリジル、ポルフィリン、カリックスアレーン、およびフェナントロリルなどである。好ましい脂肪族多座配位リガンドは、例えば、エチレンジアミン、ベンジルエチレンジアミン、ジエチレントリアミン、トリエチレンテトラミン、エチレングリコール、ならびにこれらの酢酸類、リン酸類およびメルカプタンなどである。 R is one or more M multidentate ligands. When the metal element-containing compound has two or more multidentate ligands, the plurality of multidentate ligands may be the same as or different from each other. Multidentate ligands include aromatic and aliphatic ligands. Suitable aromatic multidentate ligands are aromatic multidentate ligands including nitrogen, oxygen, phosphorus, sulfur and the like. Preferred aromatic multidentate ligands are, for example, bipyridyl, bipyrazyl, terpyridyl, porphyrin, calixarene, phenanthroyl and the like. Preferred aliphatic multidentate ligands are, for example, ethylenediamine, benzylethylenediamine, diethylenetriamine, triethylenetetramine, ethylene glycol, and their acetic acids, phosphoric acids and mercaptans.
多座配位リガンドは未置換でもよく、または当業者に公知の多数の置換基のいずれかによって置換されていてもよい。適当な置換基の例は、アルキル、置換アルキル、アリール、置換アリール、アラルキル、置換アラルキル、カルボキシレート、カルボキシアルデヒド、カルボキシアミド、シアノ、アミノ、ヒドロキシ、イミノ、ヒドロキシカルボニル、アミノカルボニル、アミジン、グアニジニウム、ウレイド、イオウ含有基、リン含有基およびN−ヒドロキシスクシンイミドのカルボン酸エステルである。 The multidentate ligand can be unsubstituted or substituted with any of a number of substituents known to those skilled in the art. Examples of suitable substituents are alkyl, substituted alkyl, aryl, substituted aryl, aralkyl, substituted aralkyl, carboxylate, carboxaldehyde, carboxamide, cyano, amino, hydroxy, imino, hydroxycarbonyl, aminocarbonyl, amidine, guanidinium, Ureido, sulfur-containing groups, phosphorus-containing groups and carboxylic acid esters of N-hydroxysuccinimide.
金属元素含有化合物は1種類以上の単座配位リガンドを有していてもよい。多数の単座配位リガンドが当業者に公知である。適当な単座配位リガンドには、例えば、一酸化炭素、シアニド、イソシアニド、ハロゲン化物、ならびに、脂肪族、芳香族および複素環ホスフィン、アミン、スチビン、アルシンが挙げられる。 The metal element-containing compound may have one or more monodentate ligands. A number of monodentate ligands are known to those skilled in the art. Suitable monodentate ligands include, for example, carbon monoxide, cyanide, isocyanide, halide, and aliphatic, aromatic and heterocyclic phosphines, amines, stibine, arsine.
RはMの種類により適宜選択すればよい。例えば、Mとして金を用いる場合、Rとして−SHや−S−S−などイオウ原子を含む基を用いれば、イオウ原子の単分子膜自己形成能を用いてRをMと結合させることができる。Mとしてルテニウムを用いる場合は、Rとしてビピリジルを用いれば、ルテニウムとピリジン環の窒素原子との配位結合によりRをMと結合させることができる。Mとしてインジウムを用いる場合は、Rとしてベンジルエチレンジアミンの酢酸類を用いれば、ベンジルエチレンジアミンの酢酸類に含まれる窒素原子やカルボキシル基とインジウムとの配位結合によりRをMと結合させることができる。 R may be appropriately selected depending on the type of M. For example, when gold is used as M, if a group containing a sulfur atom such as —SH or —S—S— is used as R, R can be bonded to M using the monolayer self-forming ability of the sulfur atom. . When ruthenium is used as M, if bipyridyl is used as R, R can be bonded to M by a coordinate bond between ruthenium and the nitrogen atom of the pyridine ring. When indium is used as M, if acetic acid of benzylethylenediamine is used as R, R can be bonded to M by a coordinate bond between a nitrogen atom or a carboxyl group contained in acetic acid of benzylethylenediamine and indium.
L1、L2、L3、L4、L5およびL6はMのリガンドであって、それぞれが同一でも異なっていてもよい。L1〜L6の具体例としては、アンモニア、塩素、ビピリジン、アントラセン、エチレンジアミン、ニトリル、オキシム、アセトン、フッ素などが挙げられる。試薬の安定性を向上させるため、または水溶性などの機能を付加するために、金属元素含有化合物がL1〜L6を含んでいることが好ましい。 L1, L2, L3, L4, L5 and L6 are ligands for M, and each may be the same or different. Specific examples of L1 to L6 include ammonia, chlorine, bipyridine, anthracene, ethylenediamine, nitrile, oxime, acetone, fluorine, and the like. In order to improve the stability of the reagent or add a function such as water solubility, the metal element-containing compound preferably contains L1 to L6.
Sは目的の有機化合物と結合可能な反応性部位を有する基であって、R、L1、L2、L3、L4、L5およびL6のうちの1個以上と共有結合している。Sは目的の有機化合物の種類によって適宜変更する必要があるため一概に特定することは困難であるが、例えば、目的の有機化合物がアミノ酸である場合、Sとしてはアミノ基と反応性を有する活性カルバメート基を用いればよい。 S is a group having a reactive site capable of binding to the target organic compound, and is covalently bonded to one or more of R, L1, L2, L3, L4, L5 and L6. Since S needs to be appropriately changed depending on the type of the target organic compound, it is difficult to specify it in general. For example, when the target organic compound is an amino acid, S has an activity having reactivity with an amino group. A carbamate group may be used.
m、t、uおよびvはそれぞれ独立して1以上の整数であり、好ましくは6以下、さらに好ましくは2以下、より好ましくは1である。
n、o、p、q、rおよびsはそれぞれ独立して0または1以上の整数であり、好ましくは6以下の整数である。
mが1であり、かつ、n、o、p、q、rおよびsの合計が0〜5の整数である化合物が特に好ましい。
vは1以上の整数であり、1〜3の整数が好ましい。
m, t, u and v are each independently an integer of 1 or more, preferably 6 or less, more preferably 2 or less, and more preferably 1.
n, o, p, q, r and s are each independently 0 or an integer of 1 or more, preferably an integer of 6 or less.
A compound in which m is 1 and the sum of n, o, p, q, r, and s is an integer of 0 to 5 is particularly preferable.
v is an integer of 1 or more, and an integer of 1 to 3 is preferable.
特に好ましい金属元素含有化合物の具体例としては、ビス(2,2’−ビピリジン)−4’−メチル−4−カルボキシビピリジン−ルテニウム N−スクシンイミジル エステル−ビス(ヘキサフルオロ−ホスフェート)が挙げられる。本化合物と上記の一般式との対応は以下のとおりである。 Specific examples of particularly preferred metal element-containing compounds include bis (2,2'-bipyridine) -4'-methyl-4-carboxybipyridine-ruthenium N-succinimidyl ester-bis (hexafluoro-phosphate). The correspondence between this compound and the above general formula is as follows.
特に好ましいもう1つの金属元素含有化合物の具体例としてはまた、1−(4−イソチオシアノベンジル)エチレンジアミン−N,N,N’,N’−四酢酸にインジウムが結合した物質が挙げられる。本化合物と上記の一般式との対応は以下のとおりである。 A specific example of another particularly preferable metal element-containing compound is a substance in which indium is bound to 1- (4-isothiocyanobenzyl) ethylenediamine-N, N, N ′, N′-tetraacetic acid. The correspondence between this compound and the above general formula is as follows.
本発明において使用する無機分析としては、金属元素含有化合物中の金属元素を分離/検出可能な分析法であれば特に限定されない。無機分析としては、例えば、誘導結合プラズマ質量分析(ICP−MS)、誘導結合プラズマ発光分光分析(ICP−AES)、マイクロ波誘導プラズマ質量分析(MIP)、蛍光X線分析(XRF)、グロー放電質量分析(GDMS)、イオン選択性電極、原子吸光分析(AAS)、核磁気共鳴分析(NMR)などが挙げられ、複数の分析法を適宜組み合わせて用いてもよい。なかでも、誘導結合プラズマ質量分析(ICP−MS)、誘導結合プラズマ発光分光分析(ICP−AES)または原子吸光分析(AAS)が好ましい。
また、本発明においては必要に応じてUV検出器など無機分析装置以外の検出器を併用することも可能である。
The inorganic analysis used in the present invention is not particularly limited as long as it is an analysis method capable of separating / detecting a metal element in a metal element-containing compound. Examples of inorganic analysis include inductively coupled plasma mass spectrometry (ICP-MS), inductively coupled plasma emission spectroscopy (ICP-AES), microwave induced plasma mass spectrometry (MIP), X-ray fluorescence analysis (XRF), and glow discharge. Examples include mass spectrometry (GDMS), ion selective electrode, atomic absorption analysis (AAS), and nuclear magnetic resonance analysis (NMR), and a plurality of analysis methods may be used in appropriate combination. Of these, inductively coupled plasma mass spectrometry (ICP-MS), inductively coupled plasma emission spectroscopy (ICP-AES) or atomic absorption spectrometry (AAS) is preferred.
In the present invention, a detector other than an inorganic analyzer such as a UV detector can be used together as necessary.
分離/検出能の向上の点から、クロマトグラフィー精製工程を含むことがさらに好ましい。本発明において、このようなクロマログラフィーは、有機化合物と金属元素含有化合物との結合体生成の前に行ってもよいし、結合体を生成した後に行ってもよい。目的の有機化合物が夾雑物を多量に含みそのままでは金属元素含有化合物との結合体生成が困難であると考えられる場合には、有機化合物を粗精製する目的で、金属元素含有化合物との結合体生成前に行うことが好ましい。しかし通常は、結合体を生成し、その後、結合体をクロマトグラフィーにより精製し、その後無機分析に供する方法が簡便である。
使用可能なクロマトグラフィーとしては、薬品分析の分野で慣用されているクロマトグラフィー手段であれば特に限定されず、例えば、ガスクロマトグラフィー、液体クロマトグラフィー、分配クロマトグラフィー、吸着クロマトグラフィー、イオン交換クロマトグラフィー、ゲルクロマトグラフィー、ペーパークロマログラフィー、薄層クロマトグラフィー、カラムクロマトグラフィー、キャピラリー電気泳動などが挙げられ、複数のクロマトグラフィーを組み合わせて用いてもよい。
なかでも、簡便さや分離能の面から総合的に判断すると、高速液体クロマトグラフィー(HPLC)またはキャピラリー電気泳動(CE)が特に好ましい。
It is more preferable to include a chromatographic purification step from the viewpoint of improvement in separation / detection ability. In the present invention, such chromatography may be performed before the formation of a conjugate of an organic compound and a metal element-containing compound, or after the formation of a conjugate. If the target organic compound contains a large amount of contaminants and it is considered difficult to form a conjugate with the metal element-containing compound, the conjugate with the metal element-containing compound is used for rough purification of the organic compound. It is preferably performed before production. However, it is usually convenient to produce a conjugate, then purify the conjugate by chromatography, and then subject it to an inorganic analysis.
The chromatography that can be used is not particularly limited as long as it is a chromatography means commonly used in the field of chemical analysis. For example, gas chromatography, liquid chromatography, partition chromatography, adsorption chromatography, ion exchange chromatography Gel chromatography, paper chromatography, thin layer chromatography, column chromatography, capillary electrophoresis, and the like, and a plurality of chromatography may be used in combination.
Among these, high-performance liquid chromatography (HPLC) or capillary electrophoresis (CE) is particularly preferable from the viewpoint of simplicity and resolution.
以下、実施例により本発明をより詳細に説明するが、本発明はこれにより何ら限定されるものではない。 EXAMPLES Hereinafter, although an Example demonstrates this invention in detail, this invention is not limited at all by this.
実施例1および2
実施例1および2で使用した機器および試薬は次のとおりである。
Examples 1 and 2
The equipment and reagents used in Examples 1 and 2 are as follows.
〈使用機器〉
ICP−MS 横河アナリティカルシステムズ社製HP4500plus環境仕様
Chamber Bergner社製Mini CE Chamber
Nebulizer Bergner社製Ari Mist Nebulizer
HPLC DIONEX社製無機分析システム
AS50 Autosampler
LC30 Chromatography Oven
AD25 Absorbance Detector
GP50 Gradient Pump
カラム
SHISEIDO社製
CAPCELLPACK Phカラム(実施例1)
NOMURA CHEMICAL社製
DEVELOSIL C30カラム(実施例2)
ブロックヒーター PIERCE社製Reacti−Therm Heating
Module
<Used equipment>
ICP-MS Yokogawa Analytical Systems' HP4500plus Environmental Specification Chamber Bergner's Mini CE Chamber
Ari Mist Nebulizer manufactured by Nebulizer Bergner
Inorganic analysis system manufactured by HPLC DIONEX
AS50 Autosampler
LC30 Chromatography Oven
AD25 Absorbance Detector
GP50 Gradient Pump
column
Made by SHISEIDO
CAPCELLPACK Ph column (Example 1)
NOMURA CHEMICAL made
DEVELOSIL C30 column (Example 2)
Block heater Reacti-Therm Heating made by PIERCE
Module
〈使用試薬〉
標準溶液 和光純薬社製原子吸光用標準溶液
(各1,000ppmのものを適宜希釈)
超純水 ミリポア社製純水製造装置より採取
DMF(ジメチルホルムアミド) 関東化学社製Ultrapureグレード
アセトニトリル(反応用) 無水高純度試薬
アセトニトリル(移動相用) 和光純薬社製クロマトグラフィー用
アミノ酸 全てシグマアルドリッチ社製アミノ酸試薬を使用
Asp:アスパラギン酸
Gly:グリシン
Tyr:チロシン
Val:バリン
Met:メチオニン
Ile:イソロイシン
Leu:ロイシン
Phe:フェニルアラニン
リン酸二水素ナトリウム 関東化学社製試薬特級
リン酸水素二ナトリウム 関東化学社製試薬特級
炭酸ナトリウム 関東化学社製試薬特級
炭酸水素ナトリウム 関東化学社製試薬特級
Ru(bpy)2(mcbpy−O−Su−ester)(PF6)2
ビス(2,2’−ビピリジン)−4’−メチル−4−カルボキシビピリジン−
ルテニウム N−スクシンイミジル エステル−ビス(ヘキサフルオロ−
ホスフェート)、フルカ社製
<Reagent used>
Standard solution Atomic absorption standard solution manufactured by Wako Pure Chemical Industries, Ltd.
(Each 1,000 ppm is diluted as appropriate)
Ultrapure water Collected from Millipore's pure water production equipment DMF (dimethylformamide) Ultrapure grade manufactured by Kanto Chemical Co., Ltd. Acetonitrile (for reaction) Anhydrous high purity reagent Acetonitrile (for mobile phase) Amino acid for chromatography manufactured by Wako Pure Chemical Industries All Sigma-Aldrich Asp: aspartic acid Gly: glycine Tyr: tyrosine Val: valine Met: methionine Ile: isoleucine Leu: leucine Phe: phenylalanine sodium dihydrogen phosphate Kanto Chemical Co., Ltd. reagent grade disodium hydrogen phosphate Kanto Chemical Co., Inc. Special reagent grade sodium carbonate Special grade reagent made by Kanto Chemical Co., Inc. Sodium hydrogen carbonate Special grade reagent made by Kanto Chemical Co., Ltd. Ru (bpy) 2 (mcbpy-O-Su-ester) (PF 6 ) 2
Bis (2,2′-bipyridine) -4′-methyl-4-carboxybipyridine
Ruthenium N-succinimidyl ester-bis (hexafluoro-
Phosphate), manufactured by Fulka
〈実験手順〉
リン酸緩衝溶液の調製
リン酸二水素ナトリウム50mmolとリン酸水素二ナトリウム50mmolを秤量し、純水にて1Lに定容した。これをろ過して不溶物を除去し、100mM pH6.8のリン酸緩衝溶液とした。
炭酸緩衝溶液の調製
炭酸ナトリウム5mmolと炭酸水素ナトリウム5mmolを秤量し、純水に溶解して塩酸でpH9.0に調整した後、100mLに定容した。これをろ過して不溶物を除去し、100mM pH9.0の炭酸緩衝溶液とした。
アミノ酸と金属含有試薬との反応
アミノ酸を約100μmol秤量し、1mLの純水に溶解してそれぞれのアミノ酸溶液を調製した。金属試薬(Ru(bpy)2(mcbpy−O−Su−ester)(PF6)2)は1mgをDMF250μLに溶解して試薬溶液とした。次に反応バイアルに炭酸緩衝溶液を190μL入れ、アミノ酸溶液10μLを加え、さらに試薬溶液50μLを加えて激しく振盪した。反応バイアルをブロックヒーターを用い55℃で一晩加熱した。冷却後、反応溶液を適宜希釈して分析試料とした(実施例1)。また、反応溶液を等量ずつ混合し、適宜希釈して分析試料とした(実施例2)。
アミノ酸反応物の分析
移動相としてA液にリン酸緩衝溶液、B液にアセトニトリル、固定相にPhカラム(実施例1)もしくはC30カラム(実施例2)を使用し、分析試料をHPLC/ICP−MSシステムに導入し、Ruの質量数であるm/z=102を検出した。
<Experimental procedure>
Preparation of
Preparation of carbonate buffer solution 5 mmol of sodium carbonate and 5 mmol of sodium bicarbonate were weighed, dissolved in pure water, adjusted to pH 9.0 with hydrochloric acid, and then adjusted to 100 mL. This was filtered to remove insoluble matter, and a carbonate buffer solution of 100 mM pH 9.0 was obtained.
Reaction of amino acid with metal-containing reagent About 100 μmol of amino acid was weighed and dissolved in 1 mL of pure water to prepare each amino acid solution. 1 mg of a metal reagent (Ru (bpy) 2 (mcbpy-O-Su-ester) (PF 6 ) 2 ) was dissolved in 250 μL of DMF to obtain a reagent solution. Next, 190 μL of carbonate buffer solution was placed in the reaction vial, 10 μL of amino acid solution was added, and 50 μL of reagent solution was further added and shaken vigorously. The reaction vial was heated at 55 ° C. overnight using a block heater. After cooling, the reaction solution was appropriately diluted to give an analytical sample (Example 1). In addition, the reaction solutions were mixed in equal amounts and appropriately diluted to obtain an analysis sample (Example 2).
As the analysis mobile phase of the amino acid reactant , phosphate buffer solution is used as solution A, acetonitrile is used as solution B, Ph column (Example 1) or C30 column (Example 2) is used as the stationary phase, and the analytical sample is HPLC / ICP- The sample was introduced into the MS system, and the mass number of Ru, m / z = 102, was detected.
〈分析結果〉
[実施例1]
HPLCの固定相に1.0×250mmのPhカラムを使用し、アミノ酸反応物の分析を行った。結果を図1に示す。100amolのGlyに相当するピークが検出された。
本発明の方法は、10amolの検出限界を得ることができ、従来の金属プローブ分析の検出限界である10pmolと比較して100万倍の高感度化を達成している。
[実施例2]
HPLCの固定相に1.0×150mmのC30カラムを使用し、アミノ酸反応物の分析を行った。結果を図2に示す。
本発明の方法は、Asp,Gly,Tyr,Val,Met,Ile,Leu,Pheの各アミノ酸に相当するピークを分離/検出することができた。各アミノ酸の検出された量を表1に示した。検出限界は各アミノ酸とも10amolであった。
<result of analysis>
[Example 1]
An amino acid reactant was analyzed using a 1.0 × 250 mm Ph column as the stationary phase of HPLC. The results are shown in FIG. A peak corresponding to 100 amol of Gly was detected.
The method of the present invention can obtain a detection limit of 10 amol, and achieves 1 million times higher sensitivity than 10 pmol which is the detection limit of the conventional metal probe analysis.
[Example 2]
Amino acid reactants were analyzed using a 1.0 × 150 mm C30 column for the HPLC stationary phase. The results are shown in FIG.
The method of the present invention was able to separate / detect peaks corresponding to Asp, Gly, Tyr, Val, Met, Ile, Leu, and Phe amino acids. The detected amounts of each amino acid are shown in Table 1. The detection limit for each amino acid was 10 amol.
実施例3
実施例3で使用した機器および試薬は次のとおりである。
Example 3
The equipment and reagents used in Example 3 are as follows.
〈使用機器〉
ICP−MS 横河アナリティカルシステムズ社製HP4500plus環境仕様
Chamber Bergner社製Mini Chamber
Nebulizer 横河アナリティカルシステムズ社製同軸Nebulizer
HPLC DIONEX社製無機分析システム
AS50 Autosampler
LC30 Chromatography Oven
AD25 Absorbance Detector
GP50 Gradient Pump
カラム
GLサイエンス社製
Inertsil ODS C18カラム
ブロックヒーター PIERCE社製Reacti−Therm Heating
Module
<Used equipment>
ICP-MS Yokogawa Analytical Systems' HP4500plus Environmental Specification Chamber Bergner's Mini Chamber
Nebulizer Coaxial Nebulizer manufactured by Yokogawa Analytical Systems
Inorganic analysis system manufactured by HPLC DIONEX
AS50 Autosampler
LC30 Chromatography Oven
AD25 Absorbance Detector
GP50 Gradient Pump
column
Made by GL Science
Inertsil ODS C18 column block heater Reacti-Therm Heating made by PIERCE
Module
〈使用試薬〉
超純水 ミリポア社製純水製造装置より採取
アセトニトリル(反応用) 無水高純度試薬
アセトニトリル(移動相用) 和光純薬製クロマトグラフィー用
ロイシン 和光純薬製
フェニルアラニン 和光純薬製
アンジオテンシンII シグマアルドリッチ社製
タフトシン(Thr−Lys−Pro−Arg)
ペプチド研究所製
酢酸アンモニウム 和光純薬製試薬特級
酢酸 関東化学製試薬特級
ホウ酸 和光純薬製試薬特級
水酸化ナトリウム 和光純薬製試薬特級
エチレンジアミン四酢酸ナトリウム(EDTA)
和光純薬製試薬特級
インジウム硝酸溶液 和光純薬製原子吸光分析用(1000ppm)
1−(4−イソチオシアノベンジル)エチレンジアミン−N,N,N’,N’−四酢酸
(イソチオシアノベンジルEDTA)
DOJINDO製
<Reagent used>
Ultrapure water Collected from Millipore pure water production equipment Acetonitrile (for reaction) Anhydrous high purity reagent Acetonitrile (for mobile phase) Wako Pure Chemicals chromatography Leucine Wako Pure Chemicals Phenylalanine Wako Pure Chemicals Angiotensin II Sigma Aldrich Tuftsin (Thr-Lys-Pro-Arg)
Peptide Laboratory Ammonium Acetate Wako Pure Chemical Reagent Special Grade Acetic Acid Kanto Chemical Reagent Special Grade Boric Acid Wako Pure Chemical Reagent Special Grade Sodium Hydroxide Wako Pure Chemical Reagent Special Grade Ethylenediaminetetraacetate Sodium
Wako Pure Chemicals reagent special grade indium nitric acid solution Wako Pure Chemicals atomic absorption analysis (1000ppm)
1- (4-Isothiocyanobenzyl) ethylenediamine-N, N, N ′, N′-tetraacetic acid
(Isothiocyanobenzyl EDTA)
Made by DOJINDO
〈実験手順〉
移動相の調製
酢酸アンモニウム100mmolを秤量し、純水にて溶解し、酢酸でpHを5.8に調整してから、アセトニトリルを30mL加えて1Lに定容して100mM pH5.8の3%アセトニトリル/100mM酢酸緩衝溶液とした。次にアセトニトリル600mLに純水を加えて1Lに定容して、60%アセトニトリル溶液とした。EDTAは5mmolを秤量し、100mLの純水で溶解して50mM EDTA溶液とした。
ホウ酸緩衝液の調製
ホウ酸20mmolを秤量し、純水に溶かして水酸化ナトリウムでpHを9.0に調整した後、100mLに定容して200mM pH9.0のホウ酸緩衝溶液とした。
アミノ酸、ペプチドとイソチオシアノベンジルEDTAとの反応
各アミノ酸およびペプチドを約0.1mmol秤量し、0.1N塩酸1mLで溶解し、さらに純水で100倍希釈して1μmol/mLの試料溶液とした。イソチオシアノベンジルEDTAは1μmolを秤量し、20%アセトニトリル溶液500μLで溶解して2μmol/mLの試薬溶液とした。
サンプルチューブに試料溶液10μLを分取して、ホウ酸緩衝液60μLを加えてよく攪拌した。さらにアセトニトリルを20μL加えてから試薬溶液10μLを加えて攪拌し、40℃で4時間加熱した。その後pH5.8の酢酸緩衝液を890μL加えて攪拌し、1000ppmのインジウム溶液10μLを加えて再び攪拌してから4℃で30分間冷却して分析試料とした。
アミノ酸・ペプチド反応物の分析
移動相としてA液に3%アセトニトリル/100mM酢酸緩衝溶液、B液に60%アセトニトリル、C液に50mM EDTA溶液、固定相に1.0×250mmのODSカラムを使用し、分析試料をHPLC/ICP−MSシステムに導入し、インジウムの質量数であるm/z=115を検出した。
<Experimental procedure>
Preparation of mobile phase 100 mmol of ammonium acetate was weighed, dissolved in pure water, adjusted to pH 5.8 with acetic acid, added with 30 mL of acetonitrile, made up to 1 L, and 3% acetonitrile with 100 mM pH 5.8. / 100 mM acetate buffer solution. Next, pure water was added to 600 mL of acetonitrile, and the volume was adjusted to 1 L to obtain a 60% acetonitrile solution. 5 mmol of EDTA was weighed and dissolved in 100 mL of pure water to obtain a 50 mM EDTA solution.
Preparation of
Reaction of amino acid, peptide and isothiocyanobenzyl EDTA Approximately 0.1 mmol of each amino acid and peptide was weighed, dissolved in 1 mL of 0.1N hydrochloric acid, and further diluted 100 times with pure water to obtain a sample solution of 1 μmol / mL. . 1 μmol of isothiocyanobenzyl EDTA was weighed and dissolved in 500 μL of 20% acetonitrile solution to obtain a 2 μmol / mL reagent solution.
10 μL of the sample solution was dispensed into a sample tube, and 60 μL of borate buffer was added and stirred well. Further, 20 μL of acetonitrile was added, 10 μL of the reagent solution was added, and the mixture was stirred and heated at 40 ° C. for 4 hours. Thereafter, 890 μL of pH 5.8 acetate buffer was added and stirred, 10 μL of 1000 ppm indium solution was added and stirred again, and then cooled at 4 ° C. for 30 minutes to prepare an analytical sample.
As the analysis mobile phase of amino acid / peptide reaction , 3% acetonitrile / 100 mM acetate buffer solution was used for solution A, 60% acetonitrile was used for solution B, 50 mM EDTA solution was used for solution C, and a 1.0 × 250 mm ODS column was used for the stationary phase. The analytical sample was introduced into the HPLC / ICP-MS system, and m / z = 115, which is the mass number of indium, was detected.
〈分析結果〉
本発明の方法を用い、アミノ酸およびペプチドに相当するピークが分離/検出された。これにより、試薬内の検出元素の結合様式および検出元素の種類はビピリジン−ルテニウム錯体以外でも可能であることが示された。また、今回はインジウムを検出元素としたが、EDTA化合物は多くの金属とキレート化合物を形成することがよく知られているため、キレート化合物を形成する元素であれば他にも検出元素として選択することができると考えられる。
<result of analysis>
Using the method of the present invention, peaks corresponding to amino acids and peptides were separated / detected. Thereby, it was shown that the coupling | bonding mode of the detection element in a reagent, and the kind of detection element are also possible other than a bipyridine-ruthenium complex. In addition, this time, indium was used as a detection element, but since EDTA compounds are well known to form chelate compounds with many metals, any other element that forms a chelate compound can be selected as a detection element. It is considered possible.
本発明の方法は、分析対象化合物の種類で検出感度がほとんど変化することがないため、LC−MSのようにイオン化率を気にする必要はなく、実際にロイシン(図3)、フェニルアラニン(図4)、タフトシン(図5)、アンジオテンシンII(図6)のいずれもほぼ同じ検出感度を得ることができた。
今回の実験ではいずれの化合物も検出限界は約1pmol(金属プローブ分析法の約10倍)であったが、反応時に添加した過剰な金属を除去すれば、実施例1および2のようにさらに高感度化が望めると考えられる。
In the method of the present invention, the detection sensitivity hardly changes depending on the type of compound to be analyzed, so there is no need to worry about the ionization rate as in LC-MS, and actually leucine (FIG. 3), phenylalanine (FIG. 4) All of tuftsin (FIG. 5) and angiotensin II (FIG. 6) were able to obtain almost the same detection sensitivity.
In this experiment, the detection limit of each compound was about 1 pmol (about 10 times that of the metal probe analysis method). However, if the excess metal added during the reaction was removed, the detection limit was higher as in Examples 1 and 2. Sensitivity can be expected.
本発明によれば、fmolやamolさらにはzmolレベルの従来よりも微量の試料で有機化合物の分析が可能となる。これにより分析による生体や環境に対する影響を大きく軽減することができる。特に有機化合物が代謝物の場合、患者や動物の負担を減らすことができ、様々なものを気軽に分析することができるようになる。例えば、これまでは大量に採血を行う必要があった血液検査も、必要な試料量が微かになるため、注射によりサンプリングする必要もなく、ほんの一滴血液を採取すればよくなる。また肝臓等の臓器に関しても切開して組織を丸ごと取り出すのではなく、キャピラリー等で細胞ひとつを取り出せば、その中の有機化合物を分析して健康状態を解析するといったことが可能になる。さらには、様々な部位から気軽に何回もサンプリングが行えるようになるので、詳細な分析ができるようになり、これまでは見つけることができなかった分析対象の僅かな変化や異常を早期に発見することが可能となる。
また、必要な試薬や溶媒が従来よりも減少することにより化学物質による汚染の危険性を低くすることが可能となるとともに、コスト面の低減も可能となる。
According to the present invention, it is possible to analyze an organic compound with a smaller amount of sample than conventional ones at fmol, amol or zmol level. Thereby, the influence on the living body and the environment by the analysis can be greatly reduced. In particular, when the organic compound is a metabolite, the burden on patients and animals can be reduced, and various things can be easily analyzed. For example, a blood test, which has been required to collect a large amount of blood until now, requires a small amount of sample. Therefore, it is not necessary to sample by injection, and only one drop of blood can be collected. In addition, if an organ such as the liver is not incised and the whole tissue is taken out, but a single cell is taken out with a capillary or the like, it is possible to analyze the organic compound in the cell to analyze the health condition. In addition, sampling can be easily performed many times from various parts, so detailed analysis can be performed, and slight changes and abnormalities in the analysis target that could not be found so far can be detected early. It becomes possible to do.
In addition, since the necessary reagents and solvents are reduced as compared with the prior art, it is possible to reduce the risk of contamination by chemical substances, and it is possible to reduce the cost.
配列番号1:このペプチドはチロシンプロテインキナーゼの基質であり、チロシンプロテインキナーゼの活性を分析するのに有用である。 SEQ ID NO: 1: This peptide is a substrate for tyrosine protein kinase and is useful for analyzing the activity of tyrosine protein kinase.
Claims (10)
(2)該結合体を無機分析に供して該結合体に含有される金属元素を分析する工程と
を含む、有機化合物の分析方法。 (1) generating a conjugate of an organic compound and a metal element-containing compound;
(2) A method for analyzing an organic compound, comprising: subjecting the conjugate to an inorganic analysis and analyzing a metal element contained in the conjugate.
[Mv(R)m(L1)n(L2)o(L3)p(L4)q(L5)r(L6)s]tSu
〔式中、
Mは、無機分析で検出可能な金属元素であり、
Rは、Mの多座配位リガンドであり、
L1、L2、L3、L4、L5およびL6はMのリガンドであって、それぞれが同一でも異なっていてもよく、
Sは前記有機化合物と結合可能な反応性部位を有する基であって、R、L1、L2、L3、L4、L5およびL6のうちの1個以上と共有結合しており、
m、t、uおよびvはそれぞれ独立して1以上の整数であり、
n、o、p、q、rおよびsはそれぞれ独立して0または1以上の整数である〕
で表される、請求項1に記載の方法。 The metal element-containing compound has the formula:
[M v (R) m (L1) n (L2) o (L3) p (L4) q (L5) r (L6) s ] t Su
[Where,
M is a metal element detectable by inorganic analysis,
R is a multidentate ligand of M;
L1, L2, L3, L4, L5 and L6 are ligands of M, which may be the same or different,
S is a group having a reactive site capable of binding to the organic compound, and is covalently bonded to one or more of R, L1, L2, L3, L4, L5 and L6;
m, t, u and v are each independently an integer of 1 or more,
n, o, p, q, r and s are each independently 0 or an integer of 1 or more.]
The method of claim 1, wherein
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005144454A JP4835036B2 (en) | 2004-05-17 | 2005-05-17 | Highly sensitive detection method for organic compounds |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004146928 | 2004-05-17 | ||
| JP2004146928 | 2004-05-17 | ||
| JP2005144454A JP4835036B2 (en) | 2004-05-17 | 2005-05-17 | Highly sensitive detection method for organic compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006003347A true JP2006003347A (en) | 2006-01-05 |
| JP4835036B2 JP4835036B2 (en) | 2011-12-14 |
Family
ID=35771844
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005144454A Expired - Fee Related JP4835036B2 (en) | 2004-05-17 | 2005-05-17 | Highly sensitive detection method for organic compounds |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4835036B2 (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010532481A (en) * | 2007-06-29 | 2010-10-07 | クエスト ダイアグノスティックス インヴェストメンツ インコーポレイテッド | Analysis of amino acids in body fluids by liquid chromatography mass spectrometry |
| US8969089B2 (en) | 2004-10-12 | 2015-03-03 | Quest Diagnostics Investments, Inc. | Analysis of amino acids in body fluid by liquid chromatography-mass spectrometry |
| WO2019198811A1 (en) * | 2018-04-13 | 2019-10-17 | 株式会社島津製作所 | Method for analyzing metal protein in biological sample |
| CN112255353A (en) * | 2020-11-05 | 2021-01-22 | 北京高麦克仪器科技有限公司 | Method for detecting arsine and phosphine in ethylene and propylene |
| US10962550B2 (en) | 2004-10-12 | 2021-03-30 | Quest Diagnostics Investments Incorporated | Analysis of amino acids in body fluid by liquid chromotography-mass spectrometry |
| US12367163B2 (en) | 2007-06-29 | 2025-07-22 | Quest Diagnostics Investments Llc | Analysis of amino acids in body fluid by liquid chromatography—mass spectrometry |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09318545A (en) * | 1996-05-31 | 1997-12-12 | Shionogi & Co Ltd | Reagent for chromatography detection by ruthenium complex chemiluminescence |
| JPH11223624A (en) * | 1997-11-12 | 1999-08-17 | Shino Test:Kk | Measuring device for substance coupled to ligand, and measuring method |
| JPH11230910A (en) * | 1998-02-16 | 1999-08-27 | Shionogi & Co Ltd | Reagent for detecting chemical emission of ruthenium complex of carboxylic acid containing benzoquinolizidine derivative |
| WO2002054075A1 (en) * | 2000-12-28 | 2002-07-11 | Mds Inc., Doing Business As Mds Sciex | Elemental analysis of tagged biologically active materials |
| JP2002241206A (en) * | 2001-02-14 | 2002-08-28 | National Institute Of Agrobiological Sciences | Antimicrobial material and method for enhancing antimicrobial activity |
| JP2002313445A (en) * | 2001-04-18 | 2002-10-25 | Hitachi Maxell Ltd | Photoelectric conversion element |
| JP2004045292A (en) * | 2002-07-12 | 2004-02-12 | Shimadzu Corp | Novel metal complex and method for determining amino acid sequence of protein using the same |
-
2005
- 2005-05-17 JP JP2005144454A patent/JP4835036B2/en not_active Expired - Fee Related
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09318545A (en) * | 1996-05-31 | 1997-12-12 | Shionogi & Co Ltd | Reagent for chromatography detection by ruthenium complex chemiluminescence |
| JPH11223624A (en) * | 1997-11-12 | 1999-08-17 | Shino Test:Kk | Measuring device for substance coupled to ligand, and measuring method |
| JPH11230910A (en) * | 1998-02-16 | 1999-08-27 | Shionogi & Co Ltd | Reagent for detecting chemical emission of ruthenium complex of carboxylic acid containing benzoquinolizidine derivative |
| WO2002054075A1 (en) * | 2000-12-28 | 2002-07-11 | Mds Inc., Doing Business As Mds Sciex | Elemental analysis of tagged biologically active materials |
| JP2002241206A (en) * | 2001-02-14 | 2002-08-28 | National Institute Of Agrobiological Sciences | Antimicrobial material and method for enhancing antimicrobial activity |
| JP2002313445A (en) * | 2001-04-18 | 2002-10-25 | Hitachi Maxell Ltd | Photoelectric conversion element |
| JP2004045292A (en) * | 2002-07-12 | 2004-02-12 | Shimadzu Corp | Novel metal complex and method for determining amino acid sequence of protein using the same |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8969089B2 (en) | 2004-10-12 | 2015-03-03 | Quest Diagnostics Investments, Inc. | Analysis of amino acids in body fluid by liquid chromatography-mass spectrometry |
| US10175208B2 (en) | 2004-10-12 | 2019-01-08 | Quest Diagnostics Investments Incorporated | Analysis of amino acids in body fluid by liquid chromotography-mass spectrometry |
| US10962550B2 (en) | 2004-10-12 | 2021-03-30 | Quest Diagnostics Investments Incorporated | Analysis of amino acids in body fluid by liquid chromotography-mass spectrometry |
| JP2010532481A (en) * | 2007-06-29 | 2010-10-07 | クエスト ダイアグノスティックス インヴェストメンツ インコーポレイテッド | Analysis of amino acids in body fluids by liquid chromatography mass spectrometry |
| JP2013137320A (en) * | 2007-06-29 | 2013-07-11 | Quest Diagnostics Investments Inc | Analysis of amino acid in body fluid by fluid chromatography mass analysis |
| JP2022119774A (en) * | 2007-06-29 | 2022-08-17 | クエスト ダイアグノスティックス インヴェストメンツ インコーポレイテッド | Analysis of amino acid in body fluid by liquid chromatography-mass spectrometry |
| JP7399214B2 (en) | 2007-06-29 | 2023-12-15 | クエスト ダイアグノスティックス インヴェストメンツ インコーポレイテッド | Amino acid analysis in body fluids by liquid chromatography mass spectrometry |
| US12367163B2 (en) | 2007-06-29 | 2025-07-22 | Quest Diagnostics Investments Llc | Analysis of amino acids in body fluid by liquid chromatography—mass spectrometry |
| WO2019198811A1 (en) * | 2018-04-13 | 2019-10-17 | 株式会社島津製作所 | Method for analyzing metal protein in biological sample |
| JPWO2019198811A1 (en) * | 2018-04-13 | 2021-03-11 | 株式会社島津製作所 | Method for analyzing metalloproteins in biological samples |
| CN112255353A (en) * | 2020-11-05 | 2021-01-22 | 北京高麦克仪器科技有限公司 | Method for detecting arsine and phosphine in ethylene and propylene |
| CN112255353B (en) * | 2020-11-05 | 2022-11-15 | 北京高麦克仪器科技有限公司 | Method for detecting arsine and phosphine in ethylene and propylene |
Also Published As
| Publication number | Publication date |
|---|---|
| JP4835036B2 (en) | 2011-12-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Iwasaki et al. | A new strategy for ionization enhancement by derivatization for mass spectrometry | |
| JP7055267B2 (en) | Analytical methods and reagents for amino functional compounds | |
| US20040161737A1 (en) | Novel luminescent metal chelates and methods for their detection | |
| Toyo’oka | LC–MS determination of bioactive molecules based upon stable isotope-coded derivatization method | |
| US8969287B2 (en) | Method for automated, large-scale measurement of the molecular flux rates of the proteome or the organeome using mass spectrometry | |
| US12498379B2 (en) | Solid-phase N-terminal peptide capture and release | |
| Zhang et al. | Simultaneous determination of arginine and seven metabolites in plasma by reversed-phase liquid chromatography with a time-controlled ortho-phthaldialdehyde precolumn derivatization | |
| Imai et al. | Fluorogenic reagents, having benzofurazan structure, in liquid chromatography | |
| CN106749402B (en) | A kind of stable isotope labeling chiral phosphorus reagent and preparation method and application thereof | |
| Giese | Detection of DNA adducts by electron capture mass spectrometry | |
| JP4835036B2 (en) | Highly sensitive detection method for organic compounds | |
| CN114486835B (en) | Cholesterol chiral molecular clamp for rapid detection of tryptophan in food | |
| JP4679368B2 (en) | Detection / separation / identification method of expressed trace protein / peptide | |
| Li et al. | Chloro-hydroxyl-merocyanine based turn-on fluorescent probes for the detection of hydrazine in water and living cells | |
| Markowski et al. | Simultaneous determination of L-arginine and 12 molecules participating in its metabolic cycle by gradient RP-HPLC method: application to human urine samples | |
| Nakano-Yasaka et al. | Development of a selective fluorescence derivatization strategy for thyroid hormones based on the Sonogashira coupling reaction | |
| JP5298390B2 (en) | Fluorosylated sialic acid derivative and analysis method thereof | |
| US20240286996A1 (en) | Naphthalenesulfonyl compounds, and preparation methods and applications | |
| Shin et al. | Determination of thiazolidine‐4‐carboxylates in urine by chloroformate derivatization and gas chromatography‐electron impact mass spectrometry | |
| KR20180001625A (en) | compound for detection of biothiol and Method for manufacturing thereof | |
| JP5119554B2 (en) | Method for simultaneous and continuous analysis of thiol compounds and simultaneous continuous analysis apparatus used therefor | |
| Miękus et al. | Ionic liquids, microextraction methods and capillary electrophoresis in biomedical research | |
| CN110554105B (en) | A kind of analytical method of chiral carboxylic acid compounds | |
| Brewer et al. | Determination of phosphorus and carbon in phosphorylated deoxynucleotides via particle beam/hollow cathode glow discharge optical emission spectroscopy (PB/HC-OES) | |
| CN114957271B (en) | Cysteine fluorescent molecular probe with strong specificity, synthesis method and application thereof, and kit containing cysteine fluorescent molecular probe |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20080124 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20100603 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100615 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100813 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100921 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20101122 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20110105 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110405 |
|
| RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20110512 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20110512 |
|
| A911 | Transfer of reconsideration by examiner before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20110602 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110628 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110802 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20110830 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20110912 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20141007 Year of fee payment: 3 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 4835036 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20141007 Year of fee payment: 3 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |